
Bioorganic and Medicinal Chemistry Letters p. 2737 - 2742 (1998)
Update date:2022-07-29
Topics:
Regan, John
Bruno, Joseph
McGarry, Daniel
Poli, Gregory
Hanney, Barbara
Bower, Shelly
Travis, Jeffrey
Sweeney, Dennis
Miller, Bruce
Souness, John
Djuric, Stevan
A new family of PDE4 inhibitors based on a benzimidazole framework is described. Several of these compounds are orally bioavailable and show efficacy in in vivo models of inflammatory disease.
View MoreContact:+1-284-4950244
Address:Box 3069, Road Town, Tortola, British Virgin Islands
Contact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Zipont chem(wuhan)Tech co.,Ltd
Contact:+86-27-87587198
Address:wuhan
Ningbo Inno Pharmchem Co., Ltd.
Contact:86-574-87319282
Address:6F-5,NO.163 RUIQING RD.,NINGBO 315000 CHINA
Tianjin Ingenochem Technology Co.,Ltd
Contact:+86-22-23677060
Address:Hitech Green Industry Park K2-9-602, Nankai district
Doi:10.1039/c4dt01643b
(2014)Doi:10.1246/cl.1998.17
(1998)Doi:10.1039/d1nj00388g
(2021)Doi:10.1016/S0957-4166(97)00599-5
(1997)Doi:10.1016/S0022-328X(97)00418-X
(1997)Doi:10.1021/om970901p
(1998)